Final report on the safety assessment of tocopherol, tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl succinate, dioleyl tocopheryl methylsilanol, potassium ascorbyl tocopheryl phosphate, and tocophersolan. International Journal of Toxicology, 2002, 21. vsk, nro 3, s. 51–116. doi:10.1080/10915810290169819ISSN 1091-5818Artikkelin verkkoversio.
fda.gov
Lung illnesses associated with use of vaping products. FDA, 8.11.2019. Artikkelin verkkoversio. Viitattu 12.11.2019.
Final report on the safety assessment of tocopherol, tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl succinate, dioleyl tocopheryl methylsilanol, potassium ascorbyl tocopheryl phosphate, and tocophersolan. International Journal of Toxicology, 2002, 21. vsk, nro 3, s. 51–116. doi:10.1080/10915810290169819ISSN 1091-5818Artikkelin verkkoversio.
Final report on the safety assessment of tocopherol, tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl succinate, dioleyl tocopheryl methylsilanol, potassium ascorbyl tocopheryl phosphate, and tocophersolan. International Journal of Toxicology, 2002, 21. vsk, nro 3, s. 51–116. doi:10.1080/10915810290169819ISSN 1091-5818Artikkelin verkkoversio.